These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4790604)

  • 41. [Pharmacokinetics of kanamycin after subcutaneous and intravenous administration in dogs].
    Calvo Wieland A; Ehinger AM; Kietzmann M; Nolte I
    Berl Munch Tierarztl Wochenschr; 2001; 114(1-2):57-60. PubMed ID: 11225500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function.
    Lanao JM; Domínguez-Gil A; Tabernero JM; De Castro S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):171-5. PubMed ID: 447438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The plasma level of kanamycin after intravenous and intramuscular injections in horses].
    Klee S; Nürnberger MC; Keller H; Ungemach FR
    Tierarztl Prax; 1996 Aug; 24(4):368-72. PubMed ID: 9012022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical experience with amikacin (BB-K8) in the urological field (author's transl)].
    Kurokawa K; Fujimura N; Yokota T
    Jpn J Antibiot; 1974 Aug; 27(4):429-33. PubMed ID: 4215902
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetics of ticarcillin in the dog.
    Tilmant L; Brown MP; Gronwall RR
    Am J Vet Res; 1985 Feb; 46(2):479-81. PubMed ID: 3922261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Toxicity and antimicrobial properties of the new aminoglycoside antibiotic 535].
    Gol'dberg LE; Filippos'iants ST; Malkova IV; Shapovalova SP
    Antibiot Med Biotekhnol; 1985 Oct; 30(10):743-7. PubMed ID: 4091511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers.
    Guibert J; Kitzis MD; Yvelin C; Acar JF
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():201-6. PubMed ID: 6573317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of tallysomycin and bleomycin in the beagle dog.
    Strong JE; Schurig JE; Issell BF; Kramer WG; Tavel AF; Florczyk AP; Crooke ST
    Cancer Treat Rep; 1979; 63(11-12):1821-7. PubMed ID: 93509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological evaluation of amikacin in neonates.
    Howard JB; McCracken GH
    Antimicrob Agents Chemother; 1975 Jul; 8(1):86-90. PubMed ID: 1164009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioavailability and pharmacokinetic profile of levofloxacin following intravenous, intramuscular and oral administration in turkeys.
    Aboubakr M; Uney K; Elmas M
    Br Poult Sci; 2014 Feb; 55(1):115-9. PubMed ID: 24735473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on the toxicity of amikacin (BB-K8). Chronic toxicity in dogs (author's transl)].
    Matsuzaki M; Yoshida A; Akutsu S; Nakamura K; Sekino M
    Jpn J Antibiot; 1975 Aug; 28(4):485-524. PubMed ID: 1160144
    [No Abstract]   [Full Text] [Related]  

  • 53. [The pharmacokinetic studies on astromicin in rats. Intramuscular, intravenous or drip intravenous administration].
    Kurimoto T; Kobayashi H; Inoue A; Okachi R
    Jpn J Antibiot; 1984 Jul; 37(7):1263-71. PubMed ID: 6492390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of dibekacin in rabbits and dogs.
    Komiya I; Murata S; Umemura K; Tomono N; Kikai S; Fujita M
    J Pharmacobiodyn; 1981 May; 4(5):362-73. PubMed ID: 7288554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kanamycin sulfate in the horse: serum, synovial fluid, peritoneal fluid, and urine concentrations after single-dose intramuscular administration.
    Brown MP; Stover SM; Kelly RH; Farver TB
    Am J Vet Res; 1981 Oct; 42(10):1823-5. PubMed ID: 7325450
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bioavailability and disposition kinetics of HI-6 in Beagle dogs.
    Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H
    Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of kanamycin in ocular tissues of calves.
    George LW; Reina-Guerra M; Baggot JD; Mihalyi J
    J Vet Pharmacol Ther; 1986 Jun; 9(2):183-91. PubMed ID: 3723661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative pharmacokinetics of amikacin and kanamycin.
    Clarke JT; Libke RD; Regamey C; Kirby WM
    Clin Pharmacol Ther; 1974 Jun; 15(6):610-6. PubMed ID: 4210297
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of a florfenicol-tylosin combination after intravenous and intramuscular administration to beagle dogs.
    Kim EY; Gebru E; Lee JS; Kim JC; Park SC
    J Vet Med Sci; 2011 Apr; 73(4):463-6. PubMed ID: 21068517
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Studies on the metabolic fate of isepamicin sulfate (HAPA-B). III. Intramuscular, intravenous and drip intravenous administration of HAPA-B in rabbits].
    Suzuki T; Somiya Y; Shirai M; Sakai A; Iwasaki M; Morishita M
    Jpn J Antibiot; 1987 Jan; 40(1):208-19. PubMed ID: 3586330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.